Page last updated: 2024-10-23

benzbromarone and Liver Neoplasms

benzbromarone has been researched along with Liver Neoplasms in 1 studies

Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Treatment with benzbromarone (BBR), a potent uricosuric drug, can be associated with liver injury."1.39Cytotoxic effects of benzbromarone and its 1'-hydroxy metabolite in human hepatocarcinoma FLC4 cells cultured on micro-space cell culture plates. ( Chiba, K; Ejiri, Y; Hosoda, M; Ishikawa, M; Kajiwara, E; Kobayashi, K; Mimura, H; Oka, H, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, K1
Kajiwara, E1
Ishikawa, M1
Mimura, H1
Oka, H1
Ejiri, Y1
Hosoda, M1
Chiba, K1

Other Studies

1 other study available for benzbromarone and Liver Neoplasms

ArticleYear
Cytotoxic effects of benzbromarone and its 1'-hydroxy metabolite in human hepatocarcinoma FLC4 cells cultured on micro-space cell culture plates.
    Drug metabolism and pharmacokinetics, 2013, Volume: 28, Issue:3

    Topics: Benzbromarone; Carcinoma, Hepatocellular; Cytotoxins; Humans; Hydroxylation; Liver Neoplasms

2013